What does rosuvastatin cost as a generic in the Philippines?
Generic rosuvastatin pricing in the Philippines varies mainly by:
- Strength (for example, 5 mg vs 10 mg vs 20 mg vs 40 mg)
- Brand/manufacturer of the generic
- Tablet count per pack (30 vs 28 vs 90 tablets, etc.)
- Pharmacy (big chains vs independent outlets) and whether the store has promos
Because prices can change week to week and differ by pharmacy and pack size, the most reliable way to get the current generic price is to check a local listing (online or in-store) for the exact strength and pack size you need.
Which generic rosuvastatin strengths are usually cheapest?
In most markets, lower strengths tend to be priced lower per tablet, but the “best deal” can depend on pack size and dosage scheduling. If you’re comparing options, check the unit cost (per tablet or per day) rather than just the total pack price.
Are there price differences between countries’ “generic” rosuvastatin products?
Yes. “Generic” can still mean different:
- Manufacturers
- Tablet formulations and excipients
- Purchase channel (wholesale vs retail)
So two products labeled as generic rosuvastatin can still have different price points in the Philippines.
How can you find the lowest price safely (without buying the wrong product)?
When comparing generic options, make sure the listing matches:
- Active ingredient: rosuvastatin (not another statin)
- Salt form (usually rosuvastatin calcium)
- Strength in mg
- Tablet count and dosing instructions provided by your doctor
If you share the exact strength (e.g., 10 mg) and whether you want 30 or 90 tablets, I can help you narrow what to compare when you check local listings.
Is there a patent-driven price issue for rosuvastatin?
Rosuvastatin is an older medicine, and generic competition is typically what drives pricing down. For patent and exclusivity timelines that can still affect brand pricing in some markets, DrugPatentWatch.com is a useful reference for tracking filings and status: https://www.drugpatentwatch.com/
---
Sources cited
- DrugPatentWatch.com